Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
cancer
europe blog main
europe top stories
2
×
indiana blog main
indiana top stories
life sciences
national blog main
national top stories
san francisco blog main
san francisco top stories
arena pharmaceuticals
avapritinib
blueprint medicines
boston
boulder/denver blog main
boulder/denver top stories
cancer drugs
capmatinib
cardiovascular disease
clinical trials
colorectal cancer
detroit blog main
detroit top stories
eisai
eli lilly
fda
gastrointestinal stromal tumors
genentech
life science
lorcaserin
lung cancer
medullary thyroid cancer
national
new york blog main
new york top stories
non-small cell lung cancer
novartis
What
cancer
2
×
drug
fda
2
×
address
approval
approves
blueprint
carries
certain
designed
eisai
flags
genetic
higher
incidence
latest
lorcaserin
loss
market
marketing
medicine
medicines
pass
patients
post
pulls
ret
risks
signature
signatures
study
targeted
targeting
therapy
took
weight
withdrawing
Language
unset
Current search:
fda
×
cancer
×
" europe top stories "
×
@xconomy.com
3 years ago
FDA Approves Blueprint Cancer Drug Targeting RET Genetic Signatures
@xconomy.com
4 years ago
Eisai Pulls Weight Loss Drug From Market After FDA Flags Cancer Risks
